Were Hedge Funds Right About DermTech, Inc. (DMTK)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback the hedge funds employing these talents and can benefit from their vast resources and knowledge in that way. We analyze quarterly 13F filings of nearly 900 hedge funds and, by looking at the smart money sentiment that surrounds a stock, we can determine whether it has the potential to beat the market over the long-term. Therefore, let’s take a closer look at what smart money thinks about DermTech, Inc. (NASDAQ:DMTK).
Jim-cramer
Bihua-chen
David-zorub-parsifal
Jim-simons
Zymeworks-inc
Regenxbio-inc
Archrock-inc
Star-bulk-carriers-corp
Nasdaq
Apparel-group-ltd
Arco-platform-limited
Meta-financial-group-inc